PHONE: +49 40 / 637 30 306
FAX: +49 40 / 637 30 307
NUMBER OF EMPLOYEES: 5
FOUNDING YEAR: 2015
Anchor Diagnostics GmbH aims to contribute to the advancement of today’s molecular diagnostic landscape by improving the combination of clinical diagnostics and therapy.
The company is dedicated to the development of solutions enabling the immediate initiation of patient treatment by supporting a speedy, innovative and reliable verification of pathogenic patterns. As the ultimate goal customers should be permitted to perform real „near patient“-testing also outside the classical diagnostic environments.
The team behind Anchor Diagnostics is having extensive experience in developing products for in vitro diagnostic use and is working for more than 15 years in the area of molecular diagnostics. The track record does include the responsibility for the design and development of more than 30 CE-IVD certified kits gaining a couple of international product registrations, including FDA- approvals.
Current products are intended for use within the field of central laboratory testing to accelerate throughput, time-to-result and the overall workflow management. These Real-Time-PCR-based diagnostic kits provide significantly reduced lead times. The particularly developed assay chemistry allows the application of different technical platforms.
Although not necessarily limited to, product development activities are focused on infectious disease-related targets.
Anchor Diagnostics is offering its expertise to interested parties and is very open for collaborations to further strengthen its network. Anchor Diagnostics is ISO 13485 certified, also for contract development and production.